Sage Therapeutics Inc's oral treatment for postpartum depression met the main goal of reducing symptoms of the condition, when compared with a placebo in a phase 3 clinical trial.
The benefits of Sage Therapeutics Inc's experimental treatment for postpartum depression outweigh risks, an advisory panel to the U.S. Food and Drug Administration said.
ORLANDO, Fla.—Infusion with the investigational compound brexanolone outperformed selective serotonin reuptake inhibitors (SSRIs) for the treatment of postpartum depression, according to a study presented at Psych Congress 2018.
Sage Therapeutics has submitted a New Drug Application to the FDA for its proposed postpartum depression treatment, the biopharmaceutical company announced.
Women who went on to experience postpartum depression had elevated cortisol levels in their hair during pregnancy, compared with other pregnant women, according to a study published online in PLoS One.
BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.
BLOG: On January 18, 2018, in Sacramento California, new mother Jessica Porten went to see a women’s health nurse practitioner. She was 4 months postpartum and had not been seen by her obstetric provider since giving birth.
My postpartum depression and anxiety went undiagnosed for six months, despite my protests to my doctor.